These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8891259)

  • 1. Sensitization to the locomotor activating effects of cocaine following cocaethylene-preexposure.
    Horger BA; Taylor JR; Elsworth JD; Jatlow PI; Roth RH
    Brain Res; 1996 Sep; 733(1):133-7. PubMed ID: 8891259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interest for delivery of cocaethylene in a sustained release emulsion vs saline evaluated on behavioral sensitization in naive and cocaine-sensitized mice.
    Noble F; Sanchez M; Lowenstein W
    Psychopharmacology (Berl); 2007 Aug; 193(3):415-21. PubMed ID: 17476479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in bioavailability between cocaine and cocaethylene and their implications for drug-reward studies.
    Nobiletti JB; Jatlow PI; Bradberry CW
    Psychopharmacology (Berl); 1994 Nov; 116(3):273-8. PubMed ID: 7892416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential behavioral responses to cocaethylene of Long-Evans and Sprague-Dawley rats: role of serotonin.
    Horowitz JM; Kristal MB; Torres G
    Synapse; 1997 May; 26(1):11-21. PubMed ID: 9097401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated administration of cocaethylene induces context-dependent sensitization to its locomotor effects.
    Prinssen EP; Kleven MS; Koek W
    Psychopharmacology (Berl); 1996 Apr; 124(4):300-5. PubMed ID: 8739544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine and alcohol interactions in the rat: effect of cocaine and alcohol pretreatments on cocaine pharmacokinetics and pharmacodynamics.
    Pan WJ; Hedaya MA
    J Pharm Sci; 1999 Dec; 88(12):1266-74. PubMed ID: 10585221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine and alcohol interactions in the rat: contribution of cocaine metabolites to the pharmacological effects.
    Pan WJ; Hedaya MA
    J Pharm Sci; 1999 Apr; 88(4):468-76. PubMed ID: 10187759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cocaethylene on dopamine and serotonin synthesis in Long-Evans and Sprague-Dawley brains.
    Baumann MH; Horowitz JM; Kristal MB; Torres G
    Brain Res; 1998 Sep; 804(2):316-9. PubMed ID: 9757074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaethylene: pharmacology, physiology and behavioral effects in humans.
    McCance EF; Price LH; Kosten TR; Jatlow PI
    J Pharmacol Exp Ther; 1995 Jul; 274(1):215-23. PubMed ID: 7616402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating properties of cocaine and cocaethylene in a behavioral preparation of Drosophila melanogaster.
    Torres G; Horowitz JM
    Synapse; 1998 Jun; 29(2):148-61. PubMed ID: 9593105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid induction of behavioral and neurochemical tolerance to cocaethylene, a model compound for agonist therapy of cocaine dependence.
    Bradberry CW; Lee T; Jatlow P
    Psychopharmacology (Berl); 1999 Sep; 146(1):87-92. PubMed ID: 10485969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual differences in cocaine-induced locomotor activity in rats: behavioral characteristics, cocaine pharmacokinetics, and the dopamine transporter.
    Gulley JM; Hoover BR; Larson GA; Zahniser NR
    Neuropsychopharmacology; 2003 Dec; 28(12):2089-101. PubMed ID: 12902997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of cocaethylene in humans following cocaine and ethanol administration.
    Harris DS; Everhart ET; Mendelson J; Jones RT
    Drug Alcohol Depend; 2003 Nov; 72(2):169-82. PubMed ID: 14636972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
    Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP
    J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaethylene-induced kindling of seizure effects: cross-specificity with cocaine.
    Meehan SM; Schechter MD
    Pharmacol Biochem Behav; 1996 Jun; 54(2):491-4. PubMed ID: 8743613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior and drug measurements in Long-Evans and Sprague-Dawley rats after ethanol-cocaine exposure.
    Horowitz JM; Bhatti E; Devi BG; Torres G
    Pharmacol Biochem Behav; 1999 Feb; 62(2):329-37. PubMed ID: 9972701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine.
    Heidbreder CA; Shippenberg TS
    Synapse; 1996 Oct; 24(2):182-92. PubMed ID: 8890460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in locomotor activity during chronic cocaine administration: effect on dopamine receptors and interaction with opioids.
    Kunko PM; French D; Izenwasser S
    J Pharmacol Exp Ther; 1998 Apr; 285(1):277-84. PubMed ID: 9536022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intravenous cocaethylene and cocaine in humans.
    Hart CL; Jatlow P; Sevarino KA; McCance-Katz EF
    Psychopharmacology (Berl); 2000 Apr; 149(2):153-62. PubMed ID: 10805610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-HT(1A) antagonist WAY 100635 can block the low-dose locomotor stimulant effects of cocaine.
    Carey R; Damianopoulos E; DePalma G
    Brain Res; 2000 Apr; 862(1-2):242-6. PubMed ID: 10799692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.